Why Biotinylated CRBN/DDB1 Became a Tool Position on Degradation-Drug Platforms
Molecular-glue and PROTAC platforms converge on CRBN-DDB1 engagement assays. This article traces the translational narrative behind the standardized tool.
- Recent Advances
- Product Information
Recent Advances
Abstract: Molecular-glue and PROTAC platforms converge on CRBN-DDB1 engagement assays. This article traces the translational narrative behind the standardized tool.
Keywords: biotinylated CRBN DDB1, molecular glue, PROTAC, protein degradation, thalidomide, standardization, UA080262
Note: The full article is published in Chinese. Please refer to the Chinese version for complete experimental details, figures and product references. For product inquiries, visit www.ua-bio.com.
Product Information






